High Dividend Yield: 15 Stocks to Watch This Week
This week’s high dividend yield screener identifies companies offering attractive dividend returns while maintaining substantial market presence. The screening criteria filtered for stocks with market capitalizations exceeding $1 billion and dividend yields above 3%, capturing established companies that prioritize shareholder income distribution.
The current market environment continues to reward income-focused investors, with several sectors showing particularly strong dividend commitments. Healthcare and consumer defensive stocks dominate this week’s results, reflecting their traditionally stable cash flow generation and dividend sustainability.
Sector composition of this week’s screener
Of the 15 stocks that cleared both the market-cap and yield screens, five come from healthcare (33% of the list by count), three from consumer defensive (20%), and two each from communication services, financial services, and consumer cyclical. Energy rounds out the list with a single representative in Chevron.
Measured by combined market capitalization, the list totals roughly $2.76 trillion in equity value. Healthcare accounts for $906 billion of that (32.8%), consumer defensive for $588 billion (21.3%), and energy for $380 billion (13.8%) on Chevron alone. The two largest sector weights — healthcare and consumer defensive — together represent 54% of total market cap on the screen, reflecting the defensive tilt typical of yield-focused universes.
Yield range and central tendency
Dividend yields across the 15 names span 3.01% (Procter & Gamble) to 6.79% (Pfizer), a 2.26x spread between the top and bottom of the list. The unweighted mean yield is 4.00% and the median is 3.75%, which sits just above the screener’s 3% entry threshold. Three names cluster above 5% (Pfizer, Verizon, AT&T) and another two sit in the 4-5% band (Bristol-Myers Squibb and U.S. Bancorp), giving the list a meaningful income tilt rather than a defensive-utility profile.
How to use this screen
This screener is a starting universe, not a buy list. Yield above 3% on a $1B+ market cap filters out micro-cap dividend traps but does not, by itself, confirm payout sustainability. Before sizing into any name, cross-check the payout ratio against the company’s free cash flow and the most recent quarterly earnings release, since both have shifted materially across the screener’s sectors since the prior reporting cycle.
| Ticker | Company | Price | Market Cap | Dividend Yield | Sector |
|---|---|---|---|---|---|
| PFE | Pfizer Inc. | $25.33 | $144.4B | 6.79% | Healthcare |
| VZ | Verizon Communications Inc. | $46.37 | $193.6B | 5.96% | Communication Services |
| T | AT&T Inc. | $24.03 | $167.0B | 4.62% | Communication Services |
| BMY | Bristol-Myers Squibb Company | $57.00 | $116.4B | 4.39% | Healthcare |
| USB | U.S. Bancorp | $53.12 | $82.5B | 3.88% | Financial Services |
| NKE | NIKE, Inc. | $41.88 | $61.9B | 3.87% | Consumer Cyclical |
| PEP | PepsiCo, Inc. | $149.12 | $203.8B | 3.82% | Consumer Defensive |
| TGT | Target Corporation | $121.54 | $55.0B | 3.75% | Consumer Defensive |
| MDT | Medtronic plc | $76.15 | $97.8B | 3.73% | Healthcare |
| CVX | Chevron Corporation | $191.06 | $380.5B | 3.62% | Energy |
| ABBV | AbbVie Inc. | $210.39 | $371.7B | 3.20% | Healthcare |
| PNC | The PNC Financial Services Group | $212.84 | $85.5B | 3.19% | Financial Services |
| HD | The Home Depot, Inc. | $297.51 | $296.3B | 3.10% | Consumer Cyclical |
| AMGN | Amgen Inc. | $326.31 | $176.1B | 3.09% | Healthcare |
| PG | The Procter & Gamble Company | $141.57 | $329.7B | 3.01% | Consumer Defensive |
Pfizer (PFE) leads the screener with a 6.79% dividend yield at $25.33 per share. The pharmaceutical giant’s $144.4 billion market cap reflects its established position in global healthcare markets.
Verizon (VZ) offers a 5.96% yield while trading at $46.37, representing the telecommunications sector’s commitment to shareholder returns. The company’s $193.6 billion valuation underscores its infrastructure investments and market position.
Communication services peer AT&T (T) provides a 4.62% dividend yield at $24.03 per share. Its $167.0 billion market capitalization positions it among the sector’s largest dividend distributors.
Bristol-Myers Squibb (BMY) rounds out the healthcare representation with a 4.39% yield at $57.00. The company’s $116.4 billion market cap reflects its diversified pharmaceutical portfolio and pipeline strength.
Regional banking leader U.S. Bancorp (USB) delivers a 3.88% yield at $53.12 per share. The $82.5 billion institution represents traditional banking sector dividend reliability.
Nike (NKE) stands out in consumer cyclicals with its 3.87% yield at $41.88, unusual for growth-oriented athletic apparel companies. The $61.9 billion market cap reflects its global brand strength and market penetration.
PepsiCo (PEP) maintains its 3.82% dividend yield at $149.12 per share, supported by a $203.8 billion market capitalization. The beverage and snack giant exemplifies consumer defensive dividend consistency.
Retail giant Target (TGT) offers a 3.75% yield at $121.54, with its $55.0 billion market cap reflecting competitive positioning. The company balances growth investments with shareholder income distribution.
Medtronic (MDT) provides medical device sector exposure with a 3.73% yield at $76.15. Its $97.8 billion valuation represents global healthcare technology leadership and steady cash generation.
Energy sector representative Chevron (CVX) delivers a 3.62% yield at $191.06 per share. The oil major’s $380.5 billion market cap demonstrates its integrated energy operations and capital allocation discipline.
AbbVie (ABBV) combines pharmaceutical innovation with a 3.20% dividend yield at $210.39. The company’s $371.7 billion market capitalization reflects its immunology and oncology franchise strength.
Financial services diversification comes through PNC Financial (PNC) at $212.84 with a 3.19% yield. The regional bank’s $85.5 billion market cap represents its mid-Atlantic and Midwest market presence.
Home Depot (HD) maintains a 3.10% yield despite its $297.51 share price and $296.3 billion market cap. The home improvement retailer balances growth reinvestment with consistent dividend payments.
Biotechnology leader Amgen (AMGN) offers a 3.09% yield at $326.31 per share. Its $176.1 billion market capitalization reflects established therapeutic franchises and biosimilar competition navigation.
Procter & Gamble (PG) concludes the screener with a 3.01% yield at $141.57, backed by a $329.7 billion market cap. The consumer goods giant represents decades of dividend growth and brand portfolio strength.
This analysis presents factual market data for informational purposes only and does not constitute investment advice. Dividend yields and stock prices fluctuate based on market conditions. Investors should conduct their own research and consult financial advisors before making investment decisions.